Tuesday, December 23, 2014 9:05:23 PM
A few things of interest:
1) CB - should hear back from them within the next few days and would be quite surprised if it's >$5k left. I'm still needing it to be $0 before any type of firm proposal is made to a target acquisition as per the previous PR.
2) speaking of the previous PR, I did a bit of research which frankly, was quite enlightening - I spoke with the management of the previous three LOI's that the company signed - iMedia, IRIS and the people at UCSF.
Apparently, the first one with iMedia years back was negated due to iMedia obtaining a $10 million investment from IDG and subsequently another $20 million from Kleiner Perkins. They'll probably be on the IPO path fairly soon so no surprise there.
IRIS - that was due to two factors: one, fairly aggressive demands on structure by IRIS' owners for equity stake. They wanted 99% of the post-transaction capital structure. two, they had a fairly sizable debt load which would have shifted to the public company as well.
UCSF - they went with another group as the outstanding CB was at the time, still pretty sizable (approximately > $100k). This created an unknown variable in terms of ability to stabilize price for proper growth funding and as evidenced by the decimated share price from the CB conversions, a smart choice for the stem cell delivery device IP owners and investors as well as UCSF.
Another overriding factor, with both IRIS and UCSF, was the lack of synergy with STOA's current business of e-commerce software and the need to completely change the underlying business. This can be readily done although better suited to a public company that is in the same line of business.
>>>>>>
I'm hoping that either rebuilding the current business into more profitable areas or finding the best acquisition target that has synergy can create some value. This will have to be tempered with the needs of both current investors as well as an incoming target company's management preference on share price/shares issued and outstanding.
Hope this helps and doesn't get attacked for grammatical errors as a sign of fraud
Happy Holidays to all.
Recent LGIQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:43:28 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 09:08:29 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 11/13/2023 09:30:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 08:11:35 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/25/2023 09:04:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2023 09:03:09 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/10/2023 10:48:27 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 04:28:19 PM
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 09/29/2023 09:20:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:32:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 05:05:22 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:57:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2023 01:51:06 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM